iStat Biomedical Co., Ltd. - Epigene

iStat, Epigene, Epigenebio, Cervical cancer test, Oral cancer test, Cancer methylation test, Epigenetic IVD assay, Non-invasive early cancer detection, DNA Methylatoin, 日祥, 甲基化基因檢測, 癌症基因檢測

iStat- Epigenetic IVD assay for cancer DNA methylation biomarkers. iStat is a Taiwan-based biotechnology company specialized in the development and manufacturing of high quality gene methylation assay products for the early detection of cervical, oral, and bladder cancers. The company provides innovative IVD products for use in the clinical laboratories and solutions for medication managements. The company is actively seeking distributors in Europe, Middle East, and Latin America, and is discussing licensing potentials with some of the global companies.

Products

 

Cervi-M make the reliable detection of methylated biomarkers in smears from the cervix for detecting cervical cancer or its precancerous lesions, The clinical performance showed that combined the results of Pap smear, both clinical sensitivity and specificity are more than 80% in detection of CIN3 or worse lesions.

Read More

The hyper- methylation of ZNF582 was founded to have close association with oral cancer. Detection the presence of hyper-methylation of ZNF582 might provide a useful tool for early detection oral cancer.

Read More

Epigene provides a simple of semi-automated DNA extraction and bisulfite conversion systems to replace the complexly manual procedure. The system produces pure gDNA ready for long-term storage up to 24 samples.

Read More

About iStat

  • A Taiwan-based biotechnology company specialized in the development and manufacturing of high quality gene methylation assay products for the early detection of cervical, oral, and bladder cancers. 
 
  • The iStat’s innovative IVD (Intro Diagnostic Device) products that are extraordinary tool, not only for risk assessment, but also for diagnosis as well as prognosis of treatments and cancers. 
 
  • The easy to use “iStat DNA Methylation assays” are performed in clinical laboratories on specimens collected non-invasively (cell scrapings), making  laboratory Gene Methylation testing faster, safer, and more affordable. 

                        

iStat Technology

iStat holds several patents and intellectual properties that on DNA methylation of cancer biomarkers.

High sensitivity

 

Sensitively detects low levels methylated biomarkers.

High specificity

 

Targets specific tumor markers.

Early detection

 

Detects earlier stage precancerous lesions.

User friendly kit design and simplified assay procedures

 

Shortens turn around time.

iStat Milestones




Latest News



FAQ

Methylation

Read More

Cervical Cancer

Read More

Oral Cancer

Read More

Bladder Cancer

Read More
iStat- Epigenetic IVD assay for cancer DNA methylation biomarkers. iStat is a Taiwan-based biotechnology company specialized in the development and manufacturing of high quality gene methylation assay products for the early detection of cervical, oral, and bladder cancers. The company provides innovative IVD products for use in the clinical laboratories and solutions for medication managements. The company is actively seeking distributors in Europe, Middle East, and Latin America, and is discussing licensing potentials with some of the global companies.
en